Document Detail

Review: Factor Xa inhibitors reduce DVT more than LMWH in total knee or hip replacement.
MedLine Citation:
PMID:  22910959     Owner:  NLM     Status:  In-Data-Review    
QUESTION How do oral direct factor Xa inhibitors compare with low-molecular-weight heparin (LMWH) for prophylaxis of venous thromboembolism (VTE) in patients having total knee replacement (TKR) or total hip replacement (THR)? REVIEW SCOPE Included studies compared oral direct factor Xa inhibitors with LMWH in patients who had TKR or THR and reported any of mortality, symptomatic deep venous thrombosis (DVT), nonfatal pulmonary embolism (PE), major bleeding, or bleeding leading to reoperation. REVIEW METHODS MEDLINE, EMBASE/Excerpta Medica, and Cochrane Central Register of Controlled Trials (all to Dec 2011); abstracts of the Congress of the International Society on Thrombosis and Haemostasis (2003 to 2011); and Annual Proceedings of the American Society of Hematology (2004 to 2011) were hand-searched for randomized controlled trials (RCTs) in any language. 22 RCTs (n = 32 159, 45% to 73% women, mean age 58 to 68 y) met the selection criteria. Drugs assessed were rivaroxaban (8 RCTs); edoxaban (4 RCTs); apixaban (4 RCTs); YM150 (2 RCTs); and betrixaban, razaxaban, TAK442, and LY517717 (1 RCT each). 11 RCTs included patients having THR, 10 included patients having TKR, and 1 included patients having either THR or TKR. Prophylaxis duration ranged from 5 to 39 days, and follow-up was < 14 days in 9 RCTs, 30 to 70 days in 12 RCTs, and ≤ 90 days in 1 RCT. Overall study quality was moderate for trials contributing to the major bleeding outcome and high for RCTs contributing to other outcomes, as assessed by the Grading of Recommendations Assessment, Development, and Evaluation approach. MAIN RESULTS Meta-analysis showed that factor Xa inhibitors reduced symptomatic DVT more than LMWH; groups did not differ for mortality, nonfatal PE, major bleeding, or bleeding leading to reoperation (Table). Subgroup analysis showed that higher doses of factor Xa inhibitors (odds ratio 2.5, 95% CI 1.4 to 4.5), but not lower doses, increased risk for major bleeding (P = 0.02 for interaction). CONCLUSION In patients having total knee or hip replacement, oral direct factor Xa inhibitors reduced symptomatic deep venous thrombosis compared with low-molecular-weight heparin but did not differ for mortality, pulmonary embolism, or bleeding.Oral direct factor Xa inhibitors vs low-molecular-weight heparin (LMWH) in total knee or hip replacement*OutcomesNumber of trials included in analyses (n)Weighted event ratesAt ≤ 5 wk unless otherwise statedFactor Xa inhibitorsLMWHRRR (95% CI)NNT (CI)Mortality (≤ 10 wk)10 (21 993)†0.24%0.25%5% (-63 to 45)Not significantSymptomatic DVT12 (21 030)‡0.27%0.58%54% (30 to 70)321 (247 to 578)RRI (CI)NNH (CI)Nonfatal PE20 (26 998)0.27%0.25%7% (-35 to 73)Not significantMajor bleeding21 (31 424)0.84%0.66%27% (-2 to 64)Not significantBleeding leading to reoperation14 (26 312)0.15%0.10%62% (-18 to 218)Not significant*DVT = deep venous thrombosis; PE = pulmonary embolism; other abbreviations defined in Glossary. RRR, RRI, NNT, NNH, and CI calculated from control event rates and odds ratios in article using a random-effects model.†Excludes 1 RCT with 0 events in either group.‡Excludes 6 RCTs with 0 events in either group.
Robert Bona
Related Documents :
22915299 - Intravitreal bevacizumab versus low-fluence photodynamic therapy for treatment of chron...
22506139 - The synergic effects of mirror therapy and neuromuscular electrical stimulation for han...
7246269 - Prognosis of giant cell arteritis including temporal arteritis and polymyalgia rheumati...
22910229 - Keloids: epidemiological aspects and reasons for refusal of surgical treatment in kinsh...
22436549 - Thoracic epidural anesthesia for coronary bypass surgery affects autonomic neural funct...
22394769 - 47 role of insulin-like growth factor-i on the functional parameters and fertility of o...
12812129 - "step by step" treatment of lateral semicircular canal canalolithiasis under videonysta...
24574019 - A prospective study of one-year clinical outcomes utilizing a composite three-dimension...
1395239 - Acetabular roof reinforcement rings.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Annals of internal medicine     Volume:  157     ISSN:  1539-3704     ISO Abbreviation:  Ann. Intern. Med.     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-08-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372351     Medline TA:  Ann Intern Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  JC2-5     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Review: Fondaparinux reduces VTE and recurrence in superficial thrombophlebitis of the leg.
Next Document:  Rivaroxaban and usual care had similar rates of recurrent VTE and bleeding in symptomatic PE.